SCHEMBL114067

SCHEMBL114067

CCCSOSCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17789226 0.83
SCHEMBL1289361 0.79 TSHR (0.38)
SCHEMBL226037 0.76 THRB (0.41)
SCHEMBL12328242 0.74
SCHEMBL6249697 0.74
SCHEMBL4672653 0.74 THRB (0.47)
SCHEMBL1151713 0.74 THRB (0.47)
SCHEMBL10479175 0.74 THRB (0.47)
SCHEMBL12344449 0.73
SCHEMBL6248634 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704832-A2 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS Biohaven Therapeutics Ltd. (VG) 2026-03-11 EP claimed
US-20260015402-A1 SMALL MOLECULE ADAPTER REGULATED, TARGET SPECIFIC CHIMERIC ANTIGEN RECEPTOR BEARING T CELLS (SMART CARS) YALE UNIVERSITY 2026-01-15 US claimed
WO-2025081133-A2 BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EXTRACELLULAR PROTEINS IN THE BRAIN YALE UNIVERSITY (US) 2025-04-17 WO claimed
WO-2024227119-A2 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-10-31 WO claimed
US-12083181-B2 Bi-functional molecules to degrade circulating proteins YALE UNIVERSITY (US) 2024-09-10 US claimed
WO-2024167879-A1 BIFUNCTIONAL MOLECULES TO TARGET DEGRADATION OF INTERLEUKIN 17A (IL-17A) BIOHAVEN THERAPEUTICS LTD. (VG) 2024-08-15 WO claimed
WO-2024167900-A2 BIFUNCTIONAL MOLECULES TO TARGET DEGRADATION OF TUMOR NECROSIS FACTOR BIOHAVEN THERAPEUTICS LTD. (VG) 2024-08-15 WO claimed
US-20240050578-A1 BI-FUNCTIONAL MOLECULES TO DEGRADE CIRCULATING PROTEINS UNIV YALE (US) 2024-02-15 US claimed
US-11767301-B2 Bi-functional molecules to degrade circulating proteins YALE UNIVERSITY (US) 2023-09-26 US claimed
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins UNIV YALE (US) 2023-07-27 US claimed
CN-101194049-A Method for electrodeposition of bronzes ENTHONE (US) 2008-06-04 CN claimed
EP-1874982-A1 METHOD FOR ELECTRODEPOSITION OF BRONZES Enthone, Inc. (US) 2008-01-09 EP claimed
CN-1319913-C Process for the oligomerization of olefins EXXONMOBIL CHEM PATENTS INC (US) 2007-06-06 CN claimed
WO-2006113473-A1 METHOD FOR ELECTRODEPOSITION OF BRONZES ENTHONE INC. (US) 2006-10-26 WO claimed
CN-1793121-A Fused salt containing asymmetrical sulfonium cation, its preparation process and application in electrochemical device UNIV SHANGHAI JIAOTONG (CN) 2006-06-28 CN claimed
CN-1575267-A Olefin oligomerization EXXONMOBIL CHEM PATENTS INC (US) 2005-02-02 CN claimed
CN-1575266-A Process for the oligomerization of olefins EXXONMOBIL CHEM PATENTS INC (US) 2005-02-02 CN claimed
CN-1139565-C Process for production of halogeno-O-hydroxydiphenyl compounds ϣ�����⻯ѧ�عɹ�˾ 2004-02-25 CN claimed
CN-1321142-A Process for preparation of 4,4'-dihalo-o-hydroxydiphenyl compounds CIBA SPECIALTY CHEMICLAS HOLDI (CH) 2001-11-07 CN claimed
CN-1203219-A Process for production of halogeno-O-hydroxydiphenyl compounds CIBA GEIGY AG (CH) 1998-12-30 CN claimed